Cortexolone | 11-脱氧皮质醇 | Cortodoxone | Glucocorticoid Steroid Hormone

首页 / / / / Cortexolone

皮甾酮 /Cortexolone {[allProObj[0].p_purity_real_show]}

货号：A576667 同义名： 11-脱氧皮质醇;可托多松 / Cortodoxone;11-Deoxycortisol

Cortodoxone is a glucocorticoid steroid hormone that can be oxygenated to cortisol (Hydrocortisone).

Cortexolone 化学结构
CAS号：152-58-9

Cortexolone 3D分子结构
CAS号：152-58-9

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Cortexolone 纯度/质量文件产品仅供科研

货号：A576667 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

Cortexolone 生物活性

描述	Cortodoxone is a glucocorticoid steroid hormone that can be oxygenated to cortisol (Hydrocortisone).

Cortexolone 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT02760277	Duchenne Muscular Dystrophy	Phase 2	Completed	-	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT03038399	Duchenne Muscular Dystrophy	Phase 2	Enrolling by invitation	January 2021	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT02760264	Duchenne Muscular Dystrophy	Phase 2	Completed	-	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikvah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<

Cortexolone 参考文献

[1]Langbein G. [Cortodoxone (cortexolone) from hyodesoxycholic acid methylester] . Pharmazie. 1975 Jan;30(1):25-9. German.

Cortexolone 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

2.89mL

0.58mL

0.29mL

14.43mL

2.89mL

1.44mL

28.86mL

5.77mL

2.89mL

Cortexolone 技术信息

CAS号	152-58-9
分子式	C₂₁H₃₀O₄
分子量	346.461

别名	11-脱氧皮质醇;可托多松;脱氧可的松 ;Cortodoxone;11-Deoxycortisol;Cortisol, 11-deoxy-;NSC-18317;Substance S;SKF 3050;SK&F 3050;Reichstein's substance S
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Sealed in dry,Room Temperature

溶解度

DMSO: 50 mg/mL(144.32 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT02760277	Duchenne Muscular Dystrophy	Phase 2	Completed	-	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT03038399	Duchenne Muscular Dystrophy	Phase 2	Enrolling by invitation	January 2021	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikwah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT02760264	Duchenne Muscular Dystrophy	Phase 2	Completed	-	United States, California ... 展开 >> University of California Davis Davis, California, United States, 95616 United States, Florida University of Florida Gainesville, Florida, United States, 32611 Nemours Children's Hospital Orlando, Florida, United States, 32827 United States, Illinois Ann & Robert H. Lurie Children's Hospital Chicago, Illinois, United States, 60611 United States, North Carolina Duke University Durham, North Carolina, United States, 27710 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75207 Australia Royal Children's Hospital Melbourne, Australia Sydney Children's Hospital Westmead, Australia Canada, Alberta Alberta Children's Hospital Calgary, Alberta, Canada, T3B 6A8 Israel Schneider Children's Medical Center Petah Tikvah, Israel, 49202 Sweden Queen Silvia Children's Hospital Gothenburg, Sweden, 41685 United Kingdom Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne, United Kingdom, NE7 7DN 收起 <<
NCT00473512	Prostatic Neoplasms	Phase 1 Phase 2	Completed	-	United Kingdom ... 展开 >> Sutton, United Kingdom 收起 <<
NCT00473512	-		Completed	-	-
NCT02368379	Prader Willi Syndrome ... 展开 >> Adrenal Insufficiency 收起 <<	Not Applicable	Completed	-	United States, Ohio ... 展开 >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 收起 <<
NCT03589144	-		Not yet recruiting	December 2019	-
NCT03491696	Depressive Disorder ... 展开 >> Hormone Disturbance 收起 <<	Phase 4	Not yet recruiting	September 2019	France ... 展开 >> Hopitaux Universitares de Strasbourg Not yet recruiting Strasbourg, Bas Rhin, France, 67000 Contact: Jack Foucher, MD +33 3 88 11 69 21 CEMNIS@chru-strasbourg.fr Contact: Ludovic C. Jeanjean, Intern +33 6 30 11 09 13 ludovic.jeanjean@icloud.com Sub-Investigator: Jack Foucher, MD Principal Investigator: Ludovic C. Jeanjean, Intern Centre Hospitalier de Rouffach Not yet recruiting Rouffach, Haut Rhin, France, 68250 Contact: Fabrice Duval, MD +33 389787018 f.duval@ch-rouffach.fr Contact: Ludovic C. Jeanjean, Intern +33 6 30 11 09 13 ludovic.jeanjean@icloud.com Sub-Investigator: Alexis Erb, MD Sub-Investigator: Fabrice Duval, MD Principal Investigator: Ludovic C. Jeanjean, Intern 收起 <<
NCT02826278	-		Unknown	August 2016	France ... 展开 >> Hopital Femme Mere Enfant Recruiting Bron, France Contact: Claire-Lise Gay, MD 收起 <<
NCT01631474	Acne Vulgaris	Phase 2	Completed	-	United States, California ... 展开 >> Dermatology Research Associates Los Angeles, California, United States, 90045 Therapeutics Clinical Research San Diego, California, United States, 92123 University Clinical Trials San Diego, California, United States, 92123 United States, Florida International Clinical Research - US, LLC Sanford, Florida, United States United States, Georgia Gwinnett Clinical Research Center, Inc. Snellville, Georgia, United States, 30078 United States, Illinois Altman Dermatology Associates Arlington Heights, Illinois, United States, 60005 United States, Indiana Indiana Clinical Trials Center Plainfield, Indiana, United States, 46168 United States, New York Marina I. Peredo, M.D., PC Smithtown, New York, United States United States, Pennsylvania Penn State Milton S. Hershey Medical Center - Dept. of Dermatology Hershey, Pennsylvania, United States, 17033 United States, Rhode Island Clinical Partners, LLC Johnston, Rhode Island, United States United States, Texas J & S Studies College Station, Texas, United States, 77845 UT Houston Health Science Center Houston, Texas, United States, 77030 United States, Virginia Virginia Clinical Research Norfolk, Virginia, United States, 23507 收起 <<
NCT02279823	Androgenetic Alopecia	Phase 2	Completed	-	United States, California ... 展开 >> Therapeutics Clinical Research San Diego, California, United States, 92123 United States, Minnesota Minnesota Clinical Study Center Fridley, Minnesota, United States, 55432 United States, Texas DermResearch, Inc. Austin, Texas, United States, 78759 收起 <<
NCT02682264	Acne Vulgaris	Phase 3	Enrolling by invitation	December 2018	-
NCT02608476	Acne Vulgaris	Phase 3	Recruiting	March 2018	United States, Arizona ... 展开 >> Johnson Dermatology Active, not recruiting Fort Smith, Arizona, United States, 72916 Clear dermatology & Aesthetic Center Active, not recruiting Scottsdale, Arizona, United States, 85255 United States, California Center for Dermatology and Laser Surgery Active, not recruiting Sacramento, California, United States, 95819 United States, Florida Belleair Research Center Active, not recruiting Pinellas Park, Florida, United States, 33781 United States, Illinois Arlington Dermatology Active, not recruiting Arlington Heights, Illinois, United States, 60005 United States, Kansas Kansas City Dermatology, PA Active, not recruiting Overland Park, Kansas, United States, 66215 United States, Maryland Maryland Laser Skin and Vein Institute Active, not recruiting Hunt Valley, Maryland, United States, 21030 United States, New York Sadick Research Group, LLC Active, not recruiting New York, New York, United States, 10075 Skin Specialty Dermatology Recruiting New York, New York, United States, 10155 Contact: Okechukwu Udogu, MD, MPH 212-223-6599 skinspecialtydermatology@gmail.com Principal Investigator: Fran Cook-Bolden, MD United States, Rhode Island Clinical Partners, LLC Active, not recruiting Johnston, Rhode Island, United States, 02919 United States, Texas Texas Dermatology and Laser Specialists Recruiting San Antonio, Texas, United States, 78218 Contact: Carla Ilie carla@TexasDLS.com Principal Investigator: John Browning, MD Progressive Clinical Research, PA Active, not recruiting San Antonio, Texas, United States, 78229 收起 <<
NCT00125554	Major Depressive Disorder	Phase 2	Completed	-	Germany ... 展开 >> Dept. of Psychiatry and Psychotherapy, UKE Hamburg, Germany, 20246 收起 <<
NCT03665194	Healthy Volunteers	Phase 1	Recruiting	September 16, 2018	United Kingdom ... 展开 >> Richmond Pharmacology Ltd Recruiting London, United Kingdom, SW17 0RE Contact: Jorg Taubel, MD FFPM 收起 <<
NCT02608450	Acne Vulgaris	Phase 3	Recruiting	March 2018	-
NCT01831960	Acne Vulgaris	Phase 2	Completed	-	United States, Idaho ... 展开 >> Northwest Clinical Trials, Inc. Boise, Idaho, United States United States, Indiana Shideler Clinical Research Center Carmel, Indiana, United States United States, Michigan Michigan Center for Research Corp. Clinton Township, Michigan, United States 收起 <<
NCT02720627	Acne Vulgaris	Phase 2	Recruiting	December 2017	United States, Arkansas ... 展开 >> Site 103 Recruiting Fort Smith, Arkansas, United States, 72916 Contact 479-649-3376 United States, California Site 101 Recruiting San Diego, California, United States, 92037 Contact 858-576-1700 ext 4295 United States, Texas Site 102 Recruiting Houston, Texas, United States, 77030 Contact 713-500-3073 收起 <<

皮甾酮 /Cortexolone {[allProObj[0].p_purity_real_show]}

Cortexolone 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Cortexolone 质控信息

Cortexolone 生物活性

Cortexolone 临床研究

Cortexolone 参考文献

Cortexolone 实验方案

Cortexolone 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

皮甾酮 /Cortexolone {[allProObj[0].p_purity_real_show]}

Cortexolone 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Cortexolone 质控信息

Cortexolone 生物活性

Cortexolone 临床研究

Cortexolone 参考文献

Cortexolone 实验方案

Cortexolone 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Cortexolone 纯度/质量文件产品仅供科研